In this study, we aimed to investigate whether aggressive MTC can be suppressed via the induction of cytochrome c-mediated apoptosis in response to the combinational anticancer treatment of cisplatin and sorafenib at a low dose compared to each agent administered alone. This evidence concerns the gene CYCS and medullary thyroid gland carcinoma.